¼¼°èÀÇ µðÁöÅÐ °Ô³ð ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Digital Genome Market, By Product, By Application, By End User, By Geography
»óǰÄÚµå : 1672786
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è µðÁöÅÐ °Ô³ð ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 353¾ï 5,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 847¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2032³â CAGRÀº 13.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 353¾ï 5,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR 13.30% 2032³â °¡Ä¡ ¿¹Ãø 847¾ï 8,000¸¸ ´Þ·¯
±×¸². µðÁöÅÐ °Ô³ð ½ÃÀå Á¡À¯À²(%), 2025³â, Áö¿ªº°
Digital Genome Market-IMG1

¼¼°è µðÁöÅÐ °Ô³ð ½ÃÀåÀº °Ô³ð ½ÃÄö½Ì ¹× µ¥ÀÌÅÍ ºÐ¼® ºñ¿ëÀÇ Ç϶ô¿¡ ÈûÀÔ¾î ÇâÈÄ 10³â°£ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °í󸮷® DNA ½ÃÄö½Ì ±â¼úÀÇ ¹ßÀüÀ¸·Î ¿¬±¸ÀÚµéÀº Àü·Ê ¾øÀÌ ºü¸¥ ¼Óµµ¿Í Àú·ÅÇÑ ºñ¿ëÀ¸·Î Àΰ£ °Ô³ð Àüü¸¦ ½ÃÄö½ÌÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·Î ÀÎÇØ À¯ÀüÁúȯ ¿¬±¸, ½Å¾à°³¹ß, Á¤¹ÐÀÇ·á, Áø´Ü µî ´Ù¾çÇÑ ºÐ¾ßÀÇ ¿¬±¸°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¿©·¯ ±â¾÷µéÀÌ Â÷¼¼´ë ½ÃÄö½Ì Ç÷§Æû, ÷´Ü ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º Åø, ÀÓ»ó ÆÇ´Ü Áö¿ø ½Ã½ºÅÛÀ» °áÇÕÇÑ ÅëÇÕ ¼Ö·ç¼ÇÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ °³Àκ° À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ±â¹ÝÇÑ Áúº´ÀÇ Á¶±â ¹ß°ß°ú Ç¥Àû Ä¡·á Á¢±ÙÀÌ °¡´ÉÇØÁ® ÇコÄÉ¾î ºÐ¾ß¸¦ Çõ½ÅÀûÀ¸·Î º¯È­½Ãų °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è µðÁöÅÐ °Ô³ð ½ÃÀåÀº DNA ½ÃÄö½Ì ±â¼úÀÇ ºñ¿ë °¨¼Ò¿Í ´õ ±ä ¸®µå¿Í ³ôÀº 󸮷®À» Á¦°øÇÏ´Â 3¼¼´ë ½ÃÄö½Ì Ç÷§ÆûÀÇ µîÀåÀ¸·Î ÀÎÇØ °Ô³ð ½ÃÄö½Ì ºñ¿ëÀÌ ³·¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ·Î ÀÎÇØ °Ô³ð ºÐ¼®ÀÌ ÀÓ»ó Àû¿ë¿¡ º¸´Ù ½±°Ô Ȱ¿ëµÉ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Á¤ºÎ ¹× ¹Î°£ ±â°üÀÇ °Ô³ð ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡µµ µðÁöÅÐ °Ô³ð ¼Ö·ç¼Ç µµÀÔ¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª °Ô³ð µ¥ÀÌÅÍ °øÀ¯¿¡ ´ëÇÑ ±ÔÁ¦¿Í À±¸®Àû ¹®Á¦°¡ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ¼÷·ÃµÈ ÀηÂÀÇ ºÎÁ·°ú ¹æ´ëÇÑ °Ô³ð µ¥ÀÌÅͼ¼Æ®¸¦ ´Ù·ç´Â µ¥ ÀÖ¾î ±â¼úÀûÀÎ ¹®Á¦µµ ½ÃÀåÀ» ¾ïÁ¦ÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. °Ô³ð µ¥ÀÌÅÍ¿Í ÅëÇÕµÈ ÀÓ»ó ÀÇ»ç°áÁ¤ Áö¿ø ½Ã½ºÅÛ °³¹ßÀº Å« ºñÁî´Ï½º ±âȸÀÔ´Ï´Ù. °Ô³ð µ¥ÀÌÅÍÀÇ ÀúÀå, ºÐ¼®, °ü¸®¸¦ À§ÇÑ Å¬¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀº Á¤¹ÐÀÇ·áÀÇ Á¢±ÙÀ» °¡¼ÓÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¼¼°èÀÇ µðÁöÅÐ °Ô³ð ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í CAGR(¿¬Æò±Õ ¼ºÀå·ü)¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

¼¼°è µðÁöÅÐ °Ô³ð ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀ» ±â¾÷ °³¿ä, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä Æ¯Â¡, ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ±â¾÷À¸·Î´Â Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, F. Hoffmann-La Roche µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

µðÁöÅÐ °Ô³ð ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è µðÁöÅÐ °Ô³ð ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ µðÁöÅÐ °Ô³ð ½ÃÀå : COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ µðÁöÅÐ °Ô³ð ½ÃÀå : Á¦Ç°º°(2020-2032³â)

Á¦6Àå ¼¼°èÀÇ µðÁöÅÐ °Ô³ð ½ÃÀå : ¿ëµµº°(2020-2032³â)

Á¦7Àå ¼¼°èÀÇ µðÁöÅÐ °Ô³ð ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°(2020-2032³â)

Á¦8Àå ¼¼°èÀÇ µðÁöÅÐ °Ô³ð ½ÃÀå : Áö¿ªº°(2020-2032³â)

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ»çÇ×

Á¦11Àå Á¶»ç ¹æ¹ý

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Digital Genome Market is estimated to be valued at USD 35.35 Bn in 2025 and is expected to reach USD 84.78 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 35.35 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.30% 2032 Value Projection: USD 84.78 Bn
Figure. Digital Genome Market Share (%), By Region 2025
Digital Genome Market - IMG1

The global digital genome market is set to grow substantially over the next decade driven by declining costs of genomic sequencing and data analysis. Advancements in technologies for high-throughput DNA sequencing are enabling researchers to sequence entire human genomes at an unprecedented speed and affordable costs. This has accelerated research in various domains including genetic disease research, drug discovery, precision medicine, and diagnostics. Several companies are developing integrated solutions combining next-generation sequencing platforms, advanced bioinformatics tools, and clinical decision support systems. This is expected to transform the healthcare sector by enabling early disease detection and targeted treatment approaches based on an individual's unique genetic profile.

Market Dynamics:

The global digital genome market is witnessing strong growth driven by several factors. Declining costs of DNA sequencing technologies and emergence of third generation sequencing platforms that provide longer reads at higher throughput are reducing the costs of genome sequencing. This is making genomic analysis accessible for clinical applications. Growing funding for genomic research from government and private organizations is also fueling the adoption of digital genome solutions. However, regulatory and ethical issues related to genomic data sharing present a challenge. Lack of skilled workforce and technical challenges in handling huge genomic datasets pose restraints on the market. Development of clinical decision support systems integrated with genomic data presents a major opportunity. Cloud-based platforms for the storage, analysis, and management of genomic data could accelerate precision medicine approaches.

Key Features of the Study:

This report provides in-depth analysis of the global digital genome market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global digital genome market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, F. Hoffmann-La Roche

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global digital genome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital genome market

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Digital Genome Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Digital Genome Market, By Product, 2020 - 2032, (USD Bn)

6. Global Digital Genome Market, By Application, 2020 - 2032, (USD Bn)

7. Global Digital Genome Market, By End User, 2020 - 2032, (USD Bn)

8. Global Digital Genome Market, By Region, 2020 - 2032, (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â